Dexmedetomidine: clinical trial finds increased risk of mortality in intensive care unit (ICU) patients aged 65 years or younger
The product information of dexmedetomidine containing products is being updated with a warning statement describing the evidence, and risk factors, for increased risk of mortality in ICU patients 65 years of age or younger.